Ask AI
HERTHENA Lung02
HERTHENA-Lung02: Phase III Trial of Patritumab Deruxtecan (HER3-DXd) vs Chemotherapy in EGFRm Advanced NSCLC After a 3rd-Generation EGFR TKI

Released: June 03, 2025

Expiration: December 02, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 03, 2025

Expiration: December 02, 2025